Blinded Antidepressant Placebo Tablets with Sertraline
Blinded placebo tablets with a sugar base, identical in appearance to sertraline antidepressant pills, packaged in kits with the active medicament for a recognized clinical trial on depression. They are put up in measured doses, meeting the scope of heading 30.06, Note 4(g) and (l), as placebos for clinical trial kits.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | 9.5% | — | 9.5% |
| 🇲🇽Mexico | 9.5% | — | 9.5% |
| 🇺🇸United States | 9.5% | — | 9.5% |
| 🇩🇪Germany | 9.5% | — | 9.5% |
| 🇯🇵Japan | 9.5% | — | 9.5% |
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the kit contains only active medicaments without placebo components
Medicaments put up in measured doses for therapeutic use fall under heading 30.04, not 30.06.
If the placebo base is not sugar-based (e.g., starch or cellulose)
Other placebo bases are classified under the residual subheading for placebos.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Ensure the clinical trial is recognized by Health Canada and have the protocol or authorization letter ready for CBSA inspection
• Declare the kits as placebos for clinical trials under tariff item 3006.93.20; if the active comparator is included, the entire kit may still qualify
• Keep records of the measured dose packaging to support classification
Related Products under Tariff item 3006.93.20
Blinded Placebo Aspirin Tablets for Migraine Trial
Inert placebo tablets with a sugar base, visually matching aspirin, packaged in blinded kits with actual aspirin for a recognized migraine clinical trial. The kits are in measured doses, qualifying as placebos under heading 30.06, Note 4(g) and (l).
Double-Blinded Sugar Powder Sachets for Vaccine Study
Powder sachets containing over 10% sugar by dry weight, used as placebos in double-blinded vaccine efficacy trials. The powder is reconstituted for oral administration and put up in measured doses for a recognized clinical trial. This product falls under tariff item 3006.93.20 as a sugar-based placebo.
Flavored Sugar Placebo Lozenges for Cough Syrup Trial
Flavored sugar placebo lozenges composed primarily of sugar (>10% dry weight), used in clinical trials comparing cough syrup efficacy. Each lozenge is individually dosed and packaged in blinded kits with active medicinals. This product is classified under tariff item 3006.93.20 as a sugar-based placebo.
High-Sugar Placebo Gummy for Pediatric Asthma Study
Chewable placebo gummies with over 10% sugar by dry weight, packaged in measured doses for double-blinded pediatric asthma inhaler trials. The gummies mimic active treatments without therapeutic ingredients and are part of a recognized clinical trial kit. This product falls under tariff item 3006.93.20 as a sugar-based placebo.
Placebo Blood Pressure Pills with Lisinopril
Sugar-based placebo tablets simulating lisinopril blood pressure medication, bundled in blinded kits with active lisinopril for cardiovascular clinical trials. Packaged in measured doses, these placebos fall under heading 30.06, Note 4(g) and (l).
Placebo Statin Capsules Packaged with Atorvastatin
Inert capsules with a sugar base, resembling atorvastatin statin drugs, packaged with genuine atorvastatin in blinded kits for cholesterol-lowering efficacy trials. These placebos are in measured doses, qualifying under heading 30.06, Note 4(g) and (l).